Brief: Island Pharmaceuticals Says Phillip Lynch Appointed Executive Chairman
15/11/2024 01:35
Nov 15 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* PHILLIP LYNCH APPOINTED EXECUTIVE CHAIRMAN
* RETIREMENT OF PAUL MACLEMAN AS EXECUTIVE CHAIRMAN
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic